Warner Chilcott To Present At The 2013 Goldman Sachs Leveraged Finance Healthcare Conference

DUBLIN, Ireland, March 4, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Executive Vice President and Chief Financial Officer, Paul Herendeen, is scheduled to speak at the 2013 Goldman Sachs Leveraged Finance Healthcare Conference on Wednesday, March 6 th at 1:20 p.m. EST.

The presentation will be simultaneously webcast at http://ir.wcrx.com/events.cfm, where an archived replay will also be available shortly thereafter.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, urology and dermatology segments of the branded pharmaceuticals market, primarily in North America.  We are a fully integrated company with internal resources dedicated to the development, manufacture and promotion of our products. WCRX-G
CONTACT: Rochelle Fuhrmann         Investor Relations         973-442-3281         rfuhrmann@wcrx.com

Warner Chilcott Logo